Search

Search Constraints

You searched for: Author/Creator Frouni, Imane

Search Results

1. Activation of mGlu2/3 receptors, a novel therapeutic approach to alleviate dyskinesia and psychosis in experimental parkinsonism. (1st November 2019)

4. Combined 5-HT2A and mGlu2 modulation for the treatment of dyskinesia and psychosis in Parkinson's disease. (15th March 2021)

6. The highly selective mGlu2 receptor positive allosteric modulator LY‐487, 379 alleviates l‐DOPA‐induced dyskinesia in the 6‐OHDA‐lesioned rat model of Parkinson's disease. (12th February 2020)